Artificial kidneys, also known as bioartificial kidneys or kidney dialyzers, are artificially produced organs that fulfill the functions of natural kidneys by filtering waste and excess fluid from the blood. They are developed to provide an alternative to conventional kidney dialysis in treating kidney failure. The artificial kidney aims to mimic natural kidney functions through microfiltration membranes, blood vessels and other components. Growing technological advancements have significantly improved the safety and efficacy of these biomimicking kidneys. As conventional dialysis procedures are time-consuming and resource intensive, artificial kidneys offer significant advantages by filtering blood outside the body in a more convenient way. The global burden of chronic kidney disease continues to rise with aging populations and growth of non-communicable diseases such as diabetes. This has increased the demand for alternate treatment options for end stage renal disease patients.
The global Artificial Kidney Market is estimated to be valued at US$ 3358.54 Mn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Get more insights on this topic: https://www.coherentmarketinsights.com/market-insight/artificial-kidney-market-2335
Market key trends:
One of the key trends in the artificial kidney market is the development of implantable and miniaturized bioartificial kidneys. Researchers are working on creating bionic kidneys that can be implanted inside the body and perform key functions of natural kidneys continuously without requiring frequent dialysis. This could help improve patients’ quality of life. Further, industry players are focused on leveraging 3D bioprinting and microfabrication technologies to miniaturize artificial kidney devices for improving portability. Such advanced bioartificial kidneys are expected to replicate kidney functions with higher effectiveness. Overall, as research in the fields of regenerative medicine, microfluidics, biometrics and tissue engineering progresses, the artificial kidney technology could get a major boost over the coming years.
Threat of new entrants: The threat of new entrants is moderate due to high capital requirements for R&D, manufacturing, and distribution network.
Bargaining power of buyers: The bargaining power of buyers is moderate as the market includes large healthcare providers and end-users have limited product options.
Bargaining power of suppliers: The bargaining power of suppliers is low due to the presence of multiple component manufacturers.
Threat of new substitutes: The threat of new substitutes is low as kidney transplant is currently the only viable substitute.
Competitive rivalry: Competition in the market is high owing to the presence of global as well as regional players.
The global artificial kidney market is expected to witness high growth. The global Artificial Kidney Market is estimated to be valued at US$ 3358.54 Mn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024 to 2031.
North America is expected to dominate the market during the forecast period owing to the rising prevalence of CKD, reimbursement policies, and technological advancements in the region. Europe is also expected to hold a significant share in the market over the forecast period due to supportive government initiatives and increasing healthcare expenditure. Asia Pacific register fastest growth rate with increasing aging population and expanding healthcare infrastructure.
Key players operating in the artificial kidney market are KAWASUMI LABORATORIES, INC., Nanodialysis, Fresenius SE & Co KGaA, Baxter, ASAHI KASEI MEDICAL CO., LTD, Medtronic, DaVita Inc, Merit Medical Systems, Nipro Medical Corporation, Nikkiso Co Ltd, Braun Melsungen AG and AWAK Technologies.
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it